SML1875

(2S,6S)-Hydroxynorketamine hydrochloride

≥98% (HPLC)

• Sinónimos: (2S,6S)-2-Amino-2-(2-chlorophenyl)-6-hydroxy-cyclohexanone hydrochloride, (2S,6S)-HNK hydrochloride
• Fórmula empírica (notación de Hill): C₁₂H₁₄ClNO₂ · HCl
• Número de CAS: 1430202-70-2
• Peso molecular: 276.16
• Código UNSPSC: 12352116
• NACRES: NA.77

Propiedades

• Nivel de calidad: 100
• Análisis: ≥98% (HPLC)
• formulario: powder
• actividad óptica: [α]/D +95 to +115°, c = 1 in H₂O
• control farmacológico: regulated under CDSA - not available from Sigma-Aldrich Canada
• condiciones de almacenamiento: desiccated
• color: white to beige
• solubilidad: H₂O: 25 mg/mL, clear
• temp. de almacenamiento: 2-8°C
• cadena SMILES: [H]Cl.ClC1=CC=CC=C1[C@](CCC[C@@H]2O)(N)C2=O

Descripción

Acciones bioquímicas o fisiológicas

(2S,6S)-Hydroxynorketamine hydrochlorideKetamine is a metabolite associated with increased locomotor activity and motor incoordination.
It has been found that the NMDAR antagonist (R,S)-ketamine must be metabolized to (2S,6S;2R,6R)-hydroxynorketamine (HNK) to have antidepressant effects. The (2R,6R)-HNK enantiomer appears to be the enantiomer most responsible for antidepressant effects, while (2S,6S)-hydroxynorketamine was associated with increased locomotor activity and motor incoordination. (2S,6S)-HNK, was also found to increase the function of the mammalian target of rapamycin (mTOR) 2-fold at 0.05 nM. (2S,6S)-HNK and (2R,6R)-HNK both inhibited intracellular concentrations of D-serine, an endogenous NMDA receptor co-agonist, with IC₅₀ values of 0.18 nM and 0.68 nM, respectively. Neither bind with high affinity to NMDA receptors, with Ki values of 21.19 μM and > 100 μM for (2S,6S)-HNK and (2R,6R)-HNK, respectively.

Información de seguridad

• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3
• Punto de inflamabilidad (°F): Not applicable
• Punto de inflamabilidad (°C): Not applicable